{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:26:19Z","timestamp":1792531579263,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Cardiac magnetic resonance imaging (CMRI) is increasingly used to evaluate cardiac involvement in SSc. We assessed changes, including inflammatory and\/or fibrotic myocardial lesions detected by CMRI, following therapeutic interventions for SSc-associated symptomatic myocarditis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective study, myocarditis was diagnosed by CMRI (2018 revised Lake Louise criteria) in 14 diffuse and 4 limited SSc patients [16\/18 women, age 56\u2009years (s.d. 11), disease duration 8\u2009years (s.d. 11), 17\/18 with lung involvement] with cardiac symptoms and abnormal findings on echocardiography (4\/18) and\/or in 24-hour Holter monitoring (12\/14). CMRI was repeated after 8\u2009months (s.d. 3) following administration of cyclophosphamide (n\u2009=\u200911, combined with corticosteroids in 3 and rituximab in 1), mycophenolate (n\u2009=\u20091), tocilizumab (n\u2009=\u20091), methotrexate\/corticosteroids (n\u2009=\u20092), corticosteroids (n\u2009=\u20091) or autologous stem cell transplantation (n\u2009=\u20092).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Functional cardiac improvement was evident by increases in left [by 5.8% (s.d. 7.8), P\u2009=\u20090.006] and right ventricular ejection fraction [by 4.5% (s.d. 11.4), P\u2009=\u20090.085] in the second CMRI compared with the first. Notably, late gadolinium enhancement, currently considered to denote replacement fibrosis, decreased by 3.1% (s.d. 3.8; P\u2009=\u20090.003), resolving in six patients. Markers of myocardial oedema, namely T2 ratio and T2 mapping, decreased by 0.27 (s.d. 0.40; P\u2009=\u20090.013) and 6.0 (s.d. 7; P\u2009=\u20090.025), respectively. Conversely, both T1 mapping, considered to reflect acute oedema and diffuse fibrosis, and extracellular volume fraction, reflecting diffuse fibrosis, remained unchanged.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>CMRI may distinguish between reversible inflammatory\/fibrotic and irreversible fibrotic lesions in SSc patients with active myocarditis, confirming the unique nature of primary cardiac involvement in SSc. Whether, and how, CMRI should be used to monitor treatment effects in SSc-associated myocarditis warrants further study.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keac504","type":"journal-article","created":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:05:00Z","timestamp":1662768300000},"page":"1535-1542","source":"Crossref","is-referenced-by-count":32,"title":["Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3720-5996","authenticated-orcid":false,"given":"Stylianos","family":"Panopoulos","sequence":"first","affiliation":[{"name":"First Department of Propaedeutic and Internal Medicine and Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, Medical School , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Mavrogeni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Onassis Cardiac Surgery Center , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-3558","authenticated-orcid":false,"given":"Charalambos","family":"Vlachopoulos","sequence":"additional","affiliation":[{"name":"First Cardiology Department, Hippokration General Hospital, National and Kapodistrian University of Athens, Medical School , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-2930","authenticated-orcid":false,"given":"Petros P","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic and Internal Medicine and Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, Medical School , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/23971983211053246","article-title":"Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF\/HFA definition","volume":"7","author":"Bruni","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"2023040420422592700_","first-page":"882","article-title":"Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group","volume":"56","author":"Bissell","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rdc.2013.10.007","article-title":"Systemic sclerosis and the heart","volume":"40","author":"Parks","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"key":"2023040420422592700_","first-page":"656","article-title":"A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)","volume":"17","author":"Follansbee","year":"1990","journal-title":"J Rheumatol"},{"issue":"Suppl 4","key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"iv14","DOI":"10.1093\/rheumatology\/kel312","article-title":"Primary myocardial involvement in systemic sclerosis","volume":"45","author":"Kahan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2023040420422592700_","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac188","article-title":"Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort","author":"Zanatta","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/2397198317747441","article-title":"Update on assessment and management of primary cardiac involvement in systemic sclerosis","volume":"3","author":"Bournia","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"e001694","DOI":"10.1136\/rmdopen-2021-001694","article-title":"All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019","volume":"7","author":"Bournia","year":"2021","journal-title":"RMD Open"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10554-017-1063-9","article-title":"Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases","volume":"34","author":"Lagan","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2016.04.158","article-title":"Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use","volume":"217","author":"Mavrogeni","year":"2016","journal-title":"Int J Cardiol"},{"key":"2023040420422592700_","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-022-08923-3","article-title":"Heart involvement in systemic sclerosis: the role of magnetic resonance imaging","author":"De Luca","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.semarthrit.2019.06.013","article-title":"T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients","volume":"50","author":"Poindron","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"e0244282","DOI":"10.1371\/journal.pone.0244282","article-title":"Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: a cardiovascular magnetic resonance study with cold pressor test","volume":"15","author":"Galea","year":"2020","journal-title":"PLoS One"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/diagnostics9040220","article-title":"Cardiovascular magnetic resonance identifies high-risk systemic sclerosis patients with normal echocardiograms and provides incremental prognostic value","volume":"9","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2397198318762888","article-title":"Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis","volume":"3","author":"Lee","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.41308","article-title":"Cardiac intravoxel incoherent motion diffusion-weighted magnetic resonance imaging with T1 mapping to assess myocardial perfusion and fibrosis in systemic sclerosis: association with cardiac events from a prospective cohort study","volume":"72","author":"Terrier","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/rheumatology\/kez494","article-title":"Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)","volume":"59","author":"Mavrogeni","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"e001689","DOI":"10.1136\/rmdopen-2021-001689","article-title":"Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers","volume":"7","author":"Dumitru","year":"2021","journal-title":"RMD Open"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.semarthrit.2019.02.005","article-title":"Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients","volume":"49","author":"Rodr\u00edguez-Reyna","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-14-42","article-title":"Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance","volume":"14","author":"Ferreira","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023040420422592700_","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac098","article-title":"Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation","author":"De Luca","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"e005242","DOI":"10.1161\/CIRCIMAGING.116.005242","article-title":"Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance","volume":"10","author":"von Knobelsdorff-Brenkenhoff","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ehjci\/jex007","article-title":"Tissue characterization by T1 and T2 mapping cardiovascular magnetic resonance imaging to monitor myocardial inflammation in healing myocarditis","volume":"18","author":"Bohnen","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"e003603","DOI":"10.1161\/JAHA.116.003603","article-title":"Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis","volume":"5","author":"Luetkens","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1532-429X-15-102","article-title":"High spatial and temporal resolution retrospective cine cardiovascular magnetic resonance from shortened free breathing real-time acquisitions","volume":"15","author":"Xue","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: a JACC White Paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Med"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12968-017-0408-9","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"20","author":"Messroghli","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.CIR.100.19.1992","article-title":"Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function","volume":"100","author":"Kim","year":"1999","journal-title":"Circulation"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","article-title":"Presentation, patterns of myocardial damage, and clinical course of viral myocarditis","volume":"114","author":"Mahrholdt","year":"2006","journal-title":"Circulation"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.jacc.2019.08.1061","article-title":"Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis","volume":"74","author":"Aquaro","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"O16","DOI":"10.1186\/1532-429X-16-S1-O16","article-title":"Performance of T1 mapping vs. T2 mapping for assessing myocardial edema","volume":"16","author":"Yu","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/diagnostics10050335","article-title":"The doubled-edged sword of T1-mapping in systemic sclerosis-a comparison with infectious myocarditis using cardiovascular magnetic resonance","volume":"10","author":"Markousis-Mavrogenis","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"e0126707","DOI":"10.1371\/journal.pone.0126707","article-title":"Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy","volume":"10","author":"Mueller","year":"2015","journal-title":"PLoS One"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/rheumatology\/kez658","article-title":"Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis","volume":"59","author":"De Luca","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/rheumatology\/kew488","article-title":"Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis","volume":"56","author":"Bissell","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"102330","DOI":"10.1016\/j.jaut.2019.102330","article-title":"Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: a prospective cohort study","volume":"106","author":"De Luca","year":"2020","journal-title":"J Autoimmun"},{"key":"2023040420422592700_","first-page":"431","article-title":"Glucocorticoid effects on myocardial performance in patients with systemic sclerosis","volume":"19","author":"Antoniades","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"8884442","DOI":"10.1155\/2020\/8884442","article-title":"Clinical outcomes of myocarditis after moderate-dose steroid therapy in systemic sclerosis: a pilot study","volume":"2020","author":"Pussadhamma","year":"2020","journal-title":"Int J Rheumatol"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/bmt.2017.188","article-title":"Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening","volume":"52","author":"Martin","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12872-017-0619-x","article-title":"Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria","volume":"17","author":"Mavrogeni","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"2023040420422592700_","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac504\/46052773\/keac504.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/4\/1535\/49750788\/keac504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/4\/1535\/49750788\/keac504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T19:14:56Z","timestamp":1701026096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/4\/1535\/6694840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,9,9]]},"published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac504","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,9,9]]}}}